Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users

<p>Abstract</p> <p>Many Canadian cities are experiencing ongoing infectious disease and overdose epidemics among injection drug users (IDUs). In particular, Human Immunodeficiency Virus (HIV) and hepatitis C Virus (HCV) have become endemic in many settings and bacterial and viral i...

Full description

Bibliographic Details
Main Authors: Wood Evan, Kerr Thomas, Lloyd-Smith Elisa, Buchner Chris, Marsh David C, Montaner Julio SG, Tyndall Mark W
Format: Article
Language:English
Published: BMC 2004-11-01
Series:Harm Reduction Journal
Online Access:http://www.harmreductionjournal.com/content/1/1/9
id doaj-52b1462c77db431ba4ba11d6a9c7b5cc
record_format Article
spelling doaj-52b1462c77db431ba4ba11d6a9c7b5cc2020-11-24T20:54:14ZengBMCHarm Reduction Journal1477-75172004-11-0111910.1186/1477-7517-1-9Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug usersWood EvanKerr ThomasLloyd-Smith ElisaBuchner ChrisMarsh David CMontaner Julio SGTyndall Mark W<p>Abstract</p> <p>Many Canadian cities are experiencing ongoing infectious disease and overdose epidemics among injection drug users (IDUs). In particular, Human Immunodeficiency Virus (HIV) and hepatitis C Virus (HCV) have become endemic in many settings and bacterial and viral infections, such as endocarditis and cellulitis, have become extremely common among this population. In an effort to reduce these public health concerns and the public order problems associated with public injection drug use, in September 2003, Vancouver, Canada opened a pilot medically supervised safer injecting facility (SIF), where IDUs can inject pre-obtained illicit drugs under the supervision of medical staff. The SIF was granted a legal exemption to operate on the condition that its impacts be rigorously evaluated. In order to ensure that the evaluation is appropriately open to scrutiny among the public health community, the present article was prepared to outline the methodology for evaluating the SIF and report on some preliminary observations. The evaluation is primarily structured around a prospective cohort of SIF users, that will examine risk behavior, blood-borne infection transmission, overdose, and health service use. These analyses will be augmented with process data from within the SIF, as well as survey's of local residents and qualitative interviews with users, staff, and key stakeholders, and standardised evaluations of public order changes. Preliminary observations suggest that the site has been successful in attracting IDUs into its programs and in turn helped to reduce public drug use. However, each of the indicators described above is the subject of a rigorous scientific evaluation that is attempting to quantify the overall impacts of the site and identify both benefits and potentially harmful consequences and it will take several years before the SIF's impacts can be appropriately examined.</p> http://www.harmreductionjournal.com/content/1/1/9
collection DOAJ
language English
format Article
sources DOAJ
author Wood Evan
Kerr Thomas
Lloyd-Smith Elisa
Buchner Chris
Marsh David C
Montaner Julio SG
Tyndall Mark W
spellingShingle Wood Evan
Kerr Thomas
Lloyd-Smith Elisa
Buchner Chris
Marsh David C
Montaner Julio SG
Tyndall Mark W
Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users
Harm Reduction Journal
author_facet Wood Evan
Kerr Thomas
Lloyd-Smith Elisa
Buchner Chris
Marsh David C
Montaner Julio SG
Tyndall Mark W
author_sort Wood Evan
title Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users
title_short Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users
title_full Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users
title_fullStr Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users
title_full_unstemmed Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users
title_sort methodology for evaluating insite: canada's first medically supervised safer injection facility for injection drug users
publisher BMC
series Harm Reduction Journal
issn 1477-7517
publishDate 2004-11-01
description <p>Abstract</p> <p>Many Canadian cities are experiencing ongoing infectious disease and overdose epidemics among injection drug users (IDUs). In particular, Human Immunodeficiency Virus (HIV) and hepatitis C Virus (HCV) have become endemic in many settings and bacterial and viral infections, such as endocarditis and cellulitis, have become extremely common among this population. In an effort to reduce these public health concerns and the public order problems associated with public injection drug use, in September 2003, Vancouver, Canada opened a pilot medically supervised safer injecting facility (SIF), where IDUs can inject pre-obtained illicit drugs under the supervision of medical staff. The SIF was granted a legal exemption to operate on the condition that its impacts be rigorously evaluated. In order to ensure that the evaluation is appropriately open to scrutiny among the public health community, the present article was prepared to outline the methodology for evaluating the SIF and report on some preliminary observations. The evaluation is primarily structured around a prospective cohort of SIF users, that will examine risk behavior, blood-borne infection transmission, overdose, and health service use. These analyses will be augmented with process data from within the SIF, as well as survey's of local residents and qualitative interviews with users, staff, and key stakeholders, and standardised evaluations of public order changes. Preliminary observations suggest that the site has been successful in attracting IDUs into its programs and in turn helped to reduce public drug use. However, each of the indicators described above is the subject of a rigorous scientific evaluation that is attempting to quantify the overall impacts of the site and identify both benefits and potentially harmful consequences and it will take several years before the SIF's impacts can be appropriately examined.</p>
url http://www.harmreductionjournal.com/content/1/1/9
work_keys_str_mv AT woodevan methodologyforevaluatinginsitecanadasfirstmedicallysupervisedsaferinjectionfacilityforinjectiondrugusers
AT kerrthomas methodologyforevaluatinginsitecanadasfirstmedicallysupervisedsaferinjectionfacilityforinjectiondrugusers
AT lloydsmithelisa methodologyforevaluatinginsitecanadasfirstmedicallysupervisedsaferinjectionfacilityforinjectiondrugusers
AT buchnerchris methodologyforevaluatinginsitecanadasfirstmedicallysupervisedsaferinjectionfacilityforinjectiondrugusers
AT marshdavidc methodologyforevaluatinginsitecanadasfirstmedicallysupervisedsaferinjectionfacilityforinjectiondrugusers
AT montanerjuliosg methodologyforevaluatinginsitecanadasfirstmedicallysupervisedsaferinjectionfacilityforinjectiondrugusers
AT tyndallmarkw methodologyforevaluatinginsitecanadasfirstmedicallysupervisedsaferinjectionfacilityforinjectiondrugusers
_version_ 1716795142299451392